Opal Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Buy
+1,066
New +$149K 0.03% 238
2025
Q3
Sell
-1,372
Closed -$152K 334
2025
Q2
$152K Buy
1,372
+8
+0.6% +$851 0.04% 221
2025
Q1
$153K Buy
+1,364
New +$141K 0.05% 211
2024
Q3
Sell
-1,196
Closed -$82.1K 581
2024
Q2
$82.1K Buy
+1,196
New +$79.8K 0.03% 302

Other funds holding GILD

Opal Wealth Advisors's GILD Position: Q1 2026 in Review

Opal Wealth Advisors opened a new position in Gilead Sciences (GILD) in Q1 2026: 1,066 shares worth $149K. The stake represents 0.03% of the portfolio and ranks #238 among its holdings. This is a return to the name: Opal Wealth Advisors previously reported a position in GILD as recently as Q2 2025.

Opal Wealth Advisors first reported a position in GILD in Q2 2024 and has held it in 4 quarters since. The position peaked at $153K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Opal Wealth Advisors held 1,066 shares of Gilead Sciences worth $149K as of Q1 2026.
  • Gilead Sciences was a new Opal Wealth Advisors position in Q1 2026.
  • Gilead Sciences made up 0.03% of Opal Wealth Advisors's portfolio in Q1 2026, its #238 holding.
  • Opal Wealth Advisors first reported a position in Gilead Sciences in Q2 2024 and has held it in 4 quarters since.
  • Opal Wealth Advisors's Gilead Sciences position peaked at $153K in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.